World

Australia government to introduce bill barring 'wage theft' on Monday

Sep 03, 2023

Canberra [Australia], September 3: Australia's Labor government will introduce legislation to close "loopholes" in workplace law, a move opposed by employer groups fearing higher costs, when parliament returns on Monday.
Workplace Minister Tony Burke said on Sunday he would introduce the bill making it a criminal offence to deliberately underpay workers, with a maximum penalty of 10 years in jail and a maximum fine of A$7.8 million ($5.0 million).
Penalties would not apply to employers who make honest mistakes, Burke said in a statement.
Details of the legislation have not been released. Burke said in a speech last week that in addition to criminalising "wage theft", the bill would make it easier for casual workers to gain permanent roles, scrutinise the use of labour hire firms to undercut minimum pay rates, and introduce minimum standards for "gig economy" workers, including in food delivery and rideshare apps.
He said on Sunday in an interview with the Australian Broadcasting Corporation the impact on business would be minimal, although "there are some people who will have to pay more". Businesses with fewer than 15 employees would be exempt from some provisions, he said in a statement.
Business Council of Australia Chief Executive Jennifer Westacott called proposed changes "unworkable" on Friday, telling Sky News, "It's going to add to cost, add to complexity, make it harder to get casual work, make it harder to employ people".
Source: Fijian Broadcasting Corporation

More news

Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment

Tampa (Florida) [US], January 7: Concept Medical Inc., a global leader in innovative drug-delivery technology, proudly reports positive outcomes from the SIRONA (Head-to-Head Comparison of SIROlimus versus Paclitaxel Drug-Eluting BallooNAngioplasty in the Femoropopliteal Artery) RCT, which show that its sirolimus-coated balloons (SCB) (MagicTouch -PTA) provide patency and functional benefits on par with paclitaxel-coated balloons for patients suffering from peripheral artery disease (PAD). The 1-year data was presented by Principal Investigator Prof. Ulf Teichgraber at the TCT USA 2024 conference in a Late-Breaking Clinical Trials Session (LBCT). Coverage by TCTMD has highlighted these findings, underscoring sirolimus-based therapy as a viable new option in femoropopliteal interventions.

Jan 07, 2025